Holen Sie sich die Stockscreener-App
1.0403
13.31%
-0.1597
Handel nachbörslich:
1.03
-0.0103
-0.99%
Schlusskurs vom Vortag:
$1.20
Offen:
$1.17
24-Stunden-Volumen:
361.98K
Relative Volume:
0.06
Marktkapitalisierung:
$6.06M
Einnahmen:
$14.64M
Nettoeinkommen (Verlust:
$-13.74M
KGV:
-0.1431
EPS:
-7.27
Netto-Cashflow:
$-5.04M
1W Leistung:
-17.44%
1M Leistung:
-59.83%
6M Leistung:
+85.83%
1J Leistung:
+69.15%
1-Tages-Spanne:
$1.0403
$1.17
1-Wochen-Bereich:
$1.0403
$1.38
52-Wochen-Spanne:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Vergleichen Sie NBY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.0403 | 7.21M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
What technical signals suggest for NovaBay Pharmaceuticals Inc. stockQuarterly Risk Review & Low Risk High Reward Ideas - newser.com
NovaBay Pharmaceuticals Inc. stock trendline breakdown2025 Performance Recap & Free Technical Confirmation Trade Alerts - newser.com
Why NovaBay Pharmaceuticals Inc. stock is popular among millennials2025 Historical Comparison & Risk Controlled Stock Pick Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. recover in the next quarterJuly 2025 Intraday Action & Free AI Powered Buy and Sell Recommendations - newser.com
Is NovaBay Pharmaceuticals Inc. stock attractive for retirement portfoliosJuly 2025 Opening Moves & Safe Entry Point Alerts - newser.com
Statistical indicators supporting NovaBay Pharmaceuticals Inc.’s strengthQuarterly Profit Summary & Smart Money Movement Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. reversing from oversold territory2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com
Institutional scanner results for NovaBay Pharmaceuticals Inc.July 2025 WrapUp & Advanced Swing Trade Entry Plans - newser.com
Custom strategy builders for tracking NovaBay Pharmaceuticals Inc.Trade Exit Summary & Safe Entry Zone Identification - newser.com
Can NovaBay Pharmaceuticals Inc. (B9P0) stock beat analyst consensusQuarterly Growth Report & Technical Pattern Recognition Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. stock hit analyst price targetsTrade Risk Assessment & Weekly Stock Performance Updates - newser.com
What institutional flow reveals about NovaBay Pharmaceuticals Inc.Market Sentiment Summary & Weekly Momentum Stock Picks - newser.com
NovaBay Pharmaceuticals CEO David Lazar to resign following stock transfer agreement - Investing.com Canada
Visual analytics tools that track NovaBay Pharmaceuticals Inc. performance2025 Geopolitical Influence & Community Consensus Trade Signals - newser.com
Published on: 2025-10-09 05:27:34 - newser.com
Using flow based indicators on NovaBay Pharmaceuticals Inc.Weekly Earnings Recap & Daily Risk Controlled Trade Plans - newser.com
Reviewing AngioSoma (OTCMKTS:SOAN) and NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) - Defense World
NovaBay Pharmaceuticals Inc Stock Analysis and ForecastPrice Volatility Patterns & Budget Friendly Portfolio Growth - earlytimes.in
Will NovaBay Pharmaceuticals Inc. (B9P0) stock outperform small cap peersMarket Rally & Weekly Market Pulse Updates - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock cheap by valuation metrics2025 AllTime Highs & Growth Focused Entry Reports - newser.com
How to read the order book for NovaBay Pharmaceuticals Inc.Weekly Volume Report & Weekly Market Pulse Updates - newser.com
What analysts say about NovaBay Pharmaceuticals Inc stockEarnings Miss Alerts & Low Cost Wealth Strategies - earlytimes.in
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
How NovaBay Pharmaceuticals Inc. (B9P0) stock reacts to monetary easingQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.47%
1.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):